MedTrace Logo

Therapeutic Effects of Compound Zhenzhu Tiaozhi Capsules in NAFLD

NCT03375580 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 196

Last updated 2017-12-19

No results posted yet for this study

Summary

This is a randomised clinical trial which aims to evaluate the efficacy of Compound Zhenzhu Tiaozhi capsules in the treatment of NAFLD and analyze the relationship between improvement in NAFLD parameters and changes in intestinal functions.

Conditions

  • Nonalcoholic Fatty Liver Disease

Interventions

DIETARY_SUPPLEMENT

TLC

transform life custom (TLC)

DRUG

metformin

0.5g metformin group，PO tid

DRUG

Compound Zhenzhu Tiaozhi capsule

Compound Zhenzhu Tiaozhi capsules consist of eight Chinese herbal medications, such as Ligustrum lucidum, Atractylodes macrocephala, Radix Salviae Miltiorrhizae, pseudo-ginseng, Astragalus membranaceus.

DRUG

Simvastatin

20mg simvastatin, PO qn

Sponsors & Collaborators

  • The First Affiliated Hospital of Guangdong Pharmaceutical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-31
Primary Completion
2019-08-30
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03375580 on ClinicalTrials.gov